Canadian partnership against cancer
French Version
In Brief
March 17, 2016
Lung cancer guidelines recommend screening for Canada's
deadliest cancer
We see progressA new guideline on screening for lung cancer with low-dose CT technology presents a new opportunity for the control of lung cancer – currently Canada's most common cause of cancer death.

The Canadian Task Force on Preventive Health Care now recommends screening using low-dose CT scans in high-risk adults aged 55-74 years who are current or former smokers with a smoking history of at least 30 pack-years, defined as the average number of packs smoked daily multiplied by the number of years of smoking.

A recent study found a 15 per cent reduction in lung cancer mortality associated with screening using low-dose CT scans compared to chest x-ray. Read more…
Special Current Oncology supplement augments evidence base for cancer economics
We can. I can. The Canadian Partnership Against Cancer is proud to collaborate with Current Oncology to present a special supplement on Canada-specific cancer costing and economic evaluation research.

Our unique health care system requires specifically Canadian studies to effectively evaluate cost differences and variability in individual interventions, care pathways and cancer care systems. Economic research is highly useful for identifying good value and high quality care, but there is an acute shortage of Canada-specific evidence available. As a result, decision makers cannot accurately assess the impact of new processes, practices and technologies to make decisions of most benefit to Canadians.

The Current Oncology supplement helps fill this gap by showcasing the work of Canadian researchers focused on answering questions pertinent to Canadian cancer control. Read more…
The Partnership welcomes new Board members and advisors
The Partnership is pleased to announce the following recent appointments:

David Lynch joined the Partnership as Vice President, Finance and Corporate Services. In this role he leads the Partnership's financial management and reporting and is responsible for its Board operations, information technology and administrative functions. Mr. Lynch brings a wide range of executive leadership experience in finance, human resources, change management and operations having worked in a number of ministries with the Ontario Public Service over the past 32 years.

Claire de Oliveira, PhD, joined the Partnership as Expert Lead, Cancer Economics. In this role, she develops health economics expertise within the Partnership and supports efforts to deepen the capacity to quantify the burden of cancer and assess the economic impact of a coordinated, pan-Canadian approach to cancer control. She also works across cancer control initiatives to quantify efficiencies and support efforts to improve the sustainability of the cancer control system.
Visit, our online hub for Canadian cancer evidence, policy and practice.
More than 1 in 3 Canadians will be diagnosed with cancer in their lifetime. Our digest, 1 in 3, makes the connection between the latest cancer evidence and what it means in practice.
cancerview digest
Twitter Facebook Youtube
The next In Brief will be
published in April.
Canadian Partnership Against Cancer 1 University Ave. Suite 300 Toronto, Ontario M5J 2P1 Canada

To remove your name from our mailing list please click here. Privacy policy. Subscribe

Production of this publication has been made possible through a financial contribution from Health Canada, through the Canadian Partnership Against Cancer. The views expressed herein represent the views of the Canadian Partnership Against Cancer.